TY - JOUR
T1 - Screening for Anxiety Disorders in Adults
T2 - US Preventive Services Task Force Recommendation Statement
AU - Barry, Michael J.
AU - Nicholson, Wanda K.
AU - Silverstein, Michael
AU - Coker, Tumaini Rucker
AU - Davidson, Karina W.
AU - Davis, Esa M.
AU - Donahue, Katrina E.
AU - Jaén, Carlos Roberto
AU - Li, Li
AU - Ogedegbe, Gbenga
AU - Pbert, Lori
AU - Rao, Goutham
AU - Ruiz, John M.
AU - Stevermer, James
AU - Tsevat, Joel
AU - Underwood, Sandra Millon
AU - Wong, John B.
N1 - Publisher Copyright: © 2023 American Medical Association. All rights reserved.
PY - 2023/6/27
Y1 - 2023/6/27
N2 - Importance: Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults. Population: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults. Recommendation: The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).
AB - Importance: Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults. Population: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults. Recommendation: The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).
UR - http://www.scopus.com/inward/record.url?scp=85163196021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163196021&partnerID=8YFLogxK
U2 - 10.1001/jama.2023.9301
DO - 10.1001/jama.2023.9301
M3 - Review article
C2 - 37338866
SN - 0098-7484
VL - 329
SP - 2163
EP - 2170
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 24
ER -